Table 4.

Utilization rates and frequency of risk factor measurement of individuals with diabetes, hypertension, and hyperlipidemia by achievement of simultaneous control of HbA_1c blood pressure, and LDL cholesterol.

	Denver Health (n=5,269)				Kaiser Permanente Colorado (n=23,458)
	No simultaneous control	Simultaneous control	Total	p-value	No simultaneous control	Simultaneous control	Total	p-value
	n=4,413	n=856	n=5,269		n=16,341	n=7,117	n=23,458
Annual utilization rates, mean (sd) / median *
Primary care visits	4.8 (5.2) / 4.0	4.9 (3.1) / 4.4	4.8 (4.9) / 4.0	0.0001	6.6 (16.8) / 4.6	6.1 (4.3) / 5.2	6.4 (14.2) / 4.8	<.0001
Specialty (cardiology, endocrinology, and renal)	0.4 (1.1) / 0.0	0.5 (1.1) / 0.0	0.4 (1.1) / 0.0	<.0001	0.6 (1.7) / 0.0	1.0 (1.9) / 0.2	0.8 (1.8) / 0.0	<.0001
ED visits	1.0 (3.7) / 0.4	0.9 (2.4) / 0.4	1.0 (3.5) / 0.4	0.82	0.5 (1.1) / 0.2	0.6 (0.9) / 0.3	0.5 (1.1) / 0.2	<.0001
Inpatient visits	0.4 (1.8) / 0.0	0.5 (2.0) / 0.0	0.4 (1.8) / 0.0	0.13	1.1 (3.2) / 0.0	1.4 (3.2) / 0.4	1.2 (3.2) / 0.18	<.0001
Annual measurement rates, mean (sd) / median *
HbA1c	2.1 (3.1) / 1.9	2.1 (0.9) / 2.0	2.1 (3.4) / 1.8	<.0001	2.6 (13.2) / 1.8	2.0 (2.3) / 1.9	2.8 (15.8) / 1.8	<.0001
Blood pressure	3.4 (4.5) / 2.5	3.5 (2.6) / 2.9	3.3 (4.8) / 2.4	<.0001	6.0 (13.7) / 4.4	6.0 (4.3) / 5.0	6.0 (16.1) / 4.1	<.0001
LDL cholesterol	1.4 (3.1) / 1.1	1.3 (0.6) / 1.2	1.4 (3.4) / 1.1	<.0001	2.4 (13.2) / 1.6	2.0 (2.3) / 1.8	2.5 (15.7) / 1.5	<.0001

^*Assessed from date when all three conditions were first present until date of last clinical measurement of any of the three conditions